Celldex Therapeutics
CLDX
#4701
Rank
C$2.70 B
Marketcap
C$40.69
Share price
-0.51%
Change (1 day)
11.34%
Change (1 year)

Market capitalization of Celldex Therapeutics (CLDX)

Market cap: C$2.70 Billion

As of December 2025 Celldex Therapeutics has a market cap of C$2.70 Billion. This makes Celldex Therapeutics the world's 4701th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celldex Therapeutics from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025C$2.70 B11.84%
2024C$2.41 B-15.98%
2023C$2.87 B0.99%
2022C$2.84 B23.79%
2021C$2.30 B160.11%
2020C$0.88 B1689.79%
2019C$49.43 M2.23%
2018C$48.35 M-90.04%
2017C$0.48 B0.81%
2016C$0.48 B-77.56%
2015C$2.14 B13.13%
2014C$1.89 B-17.5%
2013C$2.30 B435.6%
2012C$0.42 B267.8%
2011C$0.11 B-11.56%
2010C$0.13 B-15.21%
2009C$0.15 B2.39%
2008C$0.15 B310.9%
2007C$37 M-68.26%
2006C$0.11 B-28.17%
2005C$0.16 B-9.29%
2004C$0.17 B-22.19%
2003C$0.22 B112.66%
2002C$0.10 B-71.99%
2001C$0.38 B-34.39%
2000C$0.58 B243.44%
1999C$0.17 B49.84%
1998C$0.11 B24.01%
1997C$92.23 M108.19%
1996C$44.3 M

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Celldex Therapeutics was reported to be:

C$2.70 Billion
by Nasdaq info icon info icon
C$2.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
C$59.61 B 2,105.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$0.18 B-93.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.87 B-67.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$245.40 B 8,977.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$204.46 B 7,462.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$134.99 B 4,893.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
C$8.47 M-99.69%๐Ÿ‡บ๐Ÿ‡ธ USA